1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Vaccine Adjuvants Market by Product Type, Route of Administration, Disease Type, Application & Application Category - Forecasts to 2021

Vaccine Adjuvants Market: Forecasts until 2021

  • June 2016
  • 159 pages
  • ID: 3912473
In this report:
Among geographies, North America is expected to command the largest share (##.##%) of the vaccine adjuvants market in 2016, due to the rising number of awareness programs, and increasing investments by companies for vaccine research and development.
The Indian biotechnology industry was valued at USD ##.## billion in 2012, and is expected to reach USD ##.## billion by the end of 2017, growing at a CAGR of ##% [Source: India Brand Equity Foundation (IBEF)].

Summary

Table of Contents

Search Inside

The vaccine adjuvants market is forecasted to reach $769.40M by 2021 from $467.00M in 2016, at a compound annual growth rate (CAGR) of 10.50 percent. The overall vaccine adjuvants market is divided established on the basis of product class, route of administration, disease type, applications, and application categories.

On the basis of class, the vaccine adjuvants market is divided into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. The particulate adjuvants segment is intended to account for the most important share of the overall vaccine adjuvants market in 2016. Increase in this industry segment can primarily be attributed to growing investments in industry research.

On the basis of route of administration, the sector is divided into subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is forecasted to account for the biggest share of the overall vaccine adjuvants market in 2016. Rising prevalence of diseases and the need for new vaccine adjuvants with better efficacy will drive the rise of this market.

Geographically, the vaccine adjuvants market is leaded by, is monopolized by North America continent, succeeded by Europe (EU), Asia area, and the Rest of the globe. Increase in the North American segment is primarily driven by the quickly growing aging population and growing government funding in the North American countries.

The main factors providing to the rise of the vaccine adjuvants market contain rising government funding for analysis, high prevalence of diseases, expanding biotechnology and biopharmaceutical sectors, and increasing focus on improved vaccination. Moreover, growing R&D spending as well as acquisitions, collaborations, and strategic agreements by firms is another main factor driving the increase of this market.

Apart from comprehensive geographic and product review and sizing of market, the industry report also offers a competitive analysis that includes the increase strategies approved by sector actors over the last three years. Additionally, the corporation reviews include the product types, advancements, and strategies approved by the key market players to maintain and rise their companies in the industry. The above-mentioned segment research data, current market size, and forecast of the future trends will facilitate top market players and new sector entrants to make the essential decisions regarding product offerings, geographic focus, change in strategic way, and levels of output in order to remain successful in the market.

The main players in the vaccine adjuvants market are Brenntag Biosector, CSL Limited, SEPPIC, Agenus, Incorporated, Novavax, Incorporated, SPI Pharma, Incorporated, Invivogen, Avanti Polar Lipids, Incorporated, MPV Technologies, and OZ Biosciences.

Why Purchasing This Study Can Help You:

This business report will allow both established firms as well as new entrants/smaller companies to measure the pulse of the sector, which in turn will facilitate these companies collect greater segment market share. Companies obtaining the study can use any one or an aggregation of the below-mentioned five strategies (business entry, product improvement/innovative projects, industry development, industry diversification, and opposing assessment) for strengthening their market shares.

This study furnishes highlights on the following points:

• Market Uptake: Exhaustive data on the product portfolios of the top actors in the vaccine adjuvants market. The market research examines the vaccine adjuvants market by category, route of administration, disease type, applications, and target group

• Product Development/Innovative products: In-depth understanding on the next technologies, Research&development activities, and recent product launches in the vaccine adjuvants market

• opposing assessment: In-depth assessment of the market strategies, geographic and industry segments, and product review of the main players in the vaccine adjuvants market

• Market Development: Highlighted information about emerging sectors. This industry report examines the sector for different vaccine adjuvants across geographies

• industry diversification: Complete information about recent products, untapped areas, recent evolutions, and market investments in the vaccine adjuvants market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Veterinary/Animal Vaccines Market by Type, Disease, Technology - Global Forecast to 2022

Veterinary/Animal Vaccines Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

“Veterinary Vaccines market is projected to register a CAGR of 5.9%”The veterinary vaccines market is expected to reach USD 8.66 billion by 2022 from USD 6.50 billion in 2017, growing at a CAGR of ...

Global Cholera Vaccines Market 2018-2022

Cholera Vaccines Sector: Worldwide Forecast until 2022

  • $ 3500
  • Industry report
  • December 2017
  • by Infiniti Research Limited

About Cholera VaccinesThe cholera vaccines market appears to be concentrated due to the presence of few established players. The major vendors in the market compete based on pricing and presence across ...

Global Companion Animal Specialty Drugs Market 2017-2021

Companion Animal Specialty Drugs Sector: Worldwide Forecast until 2021

  • $ 3500
  • Industry report
  • November 2017
  • by Infiniti Research Limited

About Companion Animal Specialty DrugsCompanion animals are becoming a part of urban population. The factors that have contributed to increased companion animal ownership includes nuclear families and ...


ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.